Inhibitory effects of natural plant extracts on lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase

Korean Journal of Pharmacognosy

Volumn 34, Issue 1, 2003, Pages 100-108

  Yu, Hana ^a   Cho, Kyung Hyun ^a   Sok, Dai Eun ^b   Jeong, Tae Sook ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Atherosclerosis; Inflammation; Lp PLA2; Oxidized LDL; Plant extracts

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ACETIC ACID ETHYL ESTER; CHLOROFORM; HEXANE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; METHANOL; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PLANT EXTRACT; WATER;

ARTICLE; ASTILBE CHINENSIS; ATHEROSCLEROSIS; ENZYME ACTIVITY; ENZYME INHIBITION; INFLAMMATION; ISCHEMIC HEART DISEASE; POURTHIAEA VILLOSA;

EID: 0037358275     PISSN: 02533073     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Glass, C. K. and Witztum, J. L. (2001) Atherosclerosis: The road ahead. Cell 104: 503-516.
2. Lusis, A. J. (2000) Atherosclerosis. Nature 407: 233-241.
3. Ross, R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340: 233-241.
4. 2 in vascular disease. (2001) Circ. Res. 89: 298-304.
5. Paramo, J. A., Beloqui, O. and Diez, J. (2001) Atherosclerosis: Is it time for a new name? Circulation 104: e38.
6. James, S., Stuart, M. C., Ian, F., Christopher, G. I., Peter, W. M. and James, H. M. (1995) Prevention of coronary heart disease with prevention in men with hypercholesterolemia. N. Engl. J. Med. 333: 1301-1307.
7. 2 as independent predictor of coronary heart disease. N. Engl. J. Med. 343: 1148-1155.
8. 2: an emerging biomarker of coronary heart disease. Expert Rev. Mol. Diagn. 2: 17-22.
9. Tew, D. G., Southan, C., Rice, S. Q., Lawrence, M. P., Li, H., Boyd, H. F., Moores, K., Gloger, I. S. and Macphee, C. H. (1996) Purification, properties, sequencing, and cloning of a lipoprotein associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 16: 591-599.
10. 2: a potential new risk factor for coronary artery disease and a therapeutic target. Curr. Opin. Pharmacol. 1: 121-125.
11. Asano, K., Okamoto, S., Fukunaga, K., Shiomi, T., Mori, T., Iwata, M., Ikeda, Y. and Yamaguchi, K. (1999) Cellular source(s) of platelet-activating-factor acethylhydrolase activity in plasma. Biochem. Biophys. Res. Commun. 261: 511-514.
12. Prescott S. M., Zimmerman G. A., Stafforini D. M. and Mcintyre T. M. (2000) Platelet activating factor and related lipid mediators. Ann. Rev. Biochem. 69: 419-445.
13. 2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. Biochem. J. 338: 479-487.
14. 2, platelet-activating factor acetylhydrolase is expressed by macrophage in human and atherosclerotic lesion. Arterioscl. Thromb. Vasc. Biol. 19: 2909-2917.
15. 2 inhibitor, in WHHL rabbits. Atherosclerosis 151: 166.
16. 2: a tagget directed at the atheroslcerotic plaque. Expert Opin. Ther. Targets 6: 309-413.
17. 2 Bioorg. Med. Chem. Lett. 10: 2557-2561.
18. Bligh E. G. and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 912-917.
19. 2, platelet-activating factor acethylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis 150: 413-419.
20. 2 produced by Pseudomonas fluorescens DSM 11579. I. Fermentation of producing strain, isolation and biological activity. J. Antibiot. 53: 664-669.
21. 2 produced by Pseudomonas fluorescens DSM 11579. II. Physicochemical properties and structure elucidation. J. Antibiot. 53: 670-676.
22. 2 produced by Pseudomonas fluorescens DSM 11579. III. Biotransformation using naringinase. J. Antibiot. 53: 733-735.
23. 2 for evaluation in man. Bioorg. Med. Chem. Lett. 12: 2603-2606.